Dongrong Yang - Concepedia

Author

Dongrong Yang

Also Known As

D Yang, D. Yang, D.R. Yang, DONGRONG YANG, Dong-Rong Yang, Dong-rong Yang, Dongrong Yang, Dong‐Rong Yang, Dong‑Rong Yang

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Soochow University Second Affiliated Hospital of Soochow University Sir Run Run Shaw Hospital University of Rochester Medical Center China Medical University

About

Dongrong Yang is an author at Soochow University specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	530
2	Cell Biology	10	10	398
3	Engineering	4	4	64
4	Biomedical Engineering	1	1	14
5	Biostatistics	1	1	12

Dongrong Yang

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of IL‐6‐JAK/Stat3 signaling in castration‐resistant prostate cancer cells enhances the NK cell‐mediated cytotoxicity via alteration of PD‐L1/NKG2D ligand levels Lijun Xu, Mingjing Shen, Dongrong Yang, Molecular Oncology	2017	127
MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib Bing Zheng, Hua Zhu, Donghua Gu, Biochemical and Biophysical Research Communications Cell AutophagyMirna-30a-mediated Autophagy InhibitionMedicineAutophagyCell Biology	2015	126
Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer Wenyu Zhang, Jin Zang, Jing Xinhua, Journal of Translational Medicine	2014	101
Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network Jin Zhu, Sugui Wang, Wenyu Zhang, Oncotarget Systems BiologyUrologyKey MicrornasPathologyCancer Genomics	2015	71
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia Lijun Xu, Qi Ma, Jin Zhu, Molecular Medicine Reports ImmunologyImmune RegulationCell DeathImmunologic MechanismImmunotherapeutics	2018	51
Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133+ Stem/Progenitor Cells to Battle Prostate Cancer Dongrong Yang, Xianfan Ding, Jie Luo, Journal of Biological Chemistry	2013	49
Adipocytes affect castration‐resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD‐L1/NKG2D ligand levels in tumor cells Lijun Xu, Mingjing Shen, Rongying Zhu, The Prostate	2018	44
Preclinical studies using miR‐32‐5p to suppress clear cell renal cell carcinoma metastasis <i>via</i> altering the miR‐32‐5p/TR4/HGF/Met signaling Mingchao Wang, Yin Sun, Junjie Xu, International Journal of Cancer UrologyOncologyGenitourinary CancerMedicinePreclinical Studies	2018	41
Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation Yibin Zhou, Peng Gu, Jian Li, Oncology Reports Signal TransductionCell RegulationSignaling PathwayMedicineProstate Carcinogenesis	2017	40
TR4 nuclear receptor promotes prostate cancer metastasis <i>via</i> upregulation of CCL2/CCR2 signaling Xianfan Ding, Dongrong Yang, Soo Ok Lee, International Journal of Cancer	2014	38

Page 1